Streptococcus pneumoniae serotype 15A in psychiatric unit, Rhode Island, USA, 2010-2011

During a pneumococcal disease outbreak in a pediatric psychiatric unit in a hospital in Rhode Island, USA, 6 (30%) of 20 patients and staff were colonized with Streptococcus pneumoniae serotype 15A, which is not included in pneumococcal vaccines. The outbreak subsided after implementation of antimic...

Full description

Saved in:
Bibliographic Details
Published in:Emerging infectious diseases 2012-11, Vol.18 (11), p.1889-1893
Main Authors: Fleming-Dutra, Katherine, Mbaeyi, Chukwuma, Link-Gelles, Ruth, Alexander, Nicole, Guh, Alice, Forbes, Elizabeth, Beall, Bernard, Winchell, Jonas M, Carvalho, Maria da Gloria, Pimenta, Fabiana, Kodani, Maja, Vanner, Cindy, Stevens, Hilary, Brady, Diane, Caulcrick-Grimes, Mardea, Bandy, Utpala, Moore, Matthew R
Format: Article
Language:English
Subjects:
Anti-infective agents
Bacterial pneumonia
Cross infection
Cross Infection - epidemiology
Development and progression
Disease Outbreaks
Disease transmission
Dispatch
Health aspects
Hospital Units
Humans
Medical research
Medicine, Experimental
Microbial Sensitivity Tests
Nosocomial infections
pneumococcal
pneumococcal infections
Pneumococcal Infections - epidemiology
Pneumonia
pneumonia, pneumococcal, serotype 15A, bacteria, antibiotic, antimicrobial, disease outbreak
Prevention
Rhode Island - epidemiology
Risk Factors
serotype 15A
Serotyping
Streptococcus pneumoniae
Streptococcus pneumoniae - classification
Streptococcus pneumoniae - drug effects
Streptococcus pneumoniae - genetics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:During a pneumococcal disease outbreak in a pediatric psychiatric unit in a hospital in Rhode Island, USA, 6 (30%) of 20 patients and staff were colonized with Streptococcus pneumoniae serotype 15A, which is not included in pneumococcal vaccines. The outbreak subsided after implementation of antimicrobial drug prophylaxis and enhanced infection control measures.
ISSN:1080-6040
1080-6059
DOI:10.3201/eid1811.120454